The impact of antidementia drugs on real life;Der einfluss von antidementiva auf den alltag und das erieben von demenzkranken

Zeitschrift fur Gerontologie und Geriatrie

Volumn 32, Issue 3, 1999, Pages 167-171

  Kurz, A ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Activities of daily living; Antidementia drugs; Cholinesterase inhibitors; Cognition

Indexed keywords

CHOLINESTERASE INHIBITOR;

AGITATION; ALZHEIMER DISEASE; APATHY; ARTICLE; ATTENTION; COGNITION; DAILY LIFE ACTIVITY; DEGENERATIVE DISEASE; DELUSION; DEMENTIA; HALLUCINATION; HUMAN; INTERPERSONAL COMMUNICATION; MEMORY;

ACTIVITIES OF DAILY LIVING; AGED; CHOLINESTERASE INHIBITORS; CLINICAL TRIALS; DEMENTIA; HUMANS; MUSCARINIC AGONISTS; NEUROPSYCHOLOGICAL TESTS; NOOTROPIC AGENTS; PHYSOSTIGMINE; SICK ROLE; TREATMENT OUTCOME;

EID: 0032771094     PISSN: 09486704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003910050101     Document Type: Article

References (19)

1. Bodick NC, Offen WW, Levey A, Cutler NR, Gauthier SG, Satlin A, Shannon HE, Tollefson GD, Rasmussen K, Bymaster FP, et al (1997) Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer's disease. Arch Neurol 54: 465-473
2. Corey-Bloom J, Anand R, Veach J (1998) A randomized trial evaluating the efficacy and safety of ENA-713 (Rivastigmine tartrate), a new cholinesterase inhibitor, in patients with mild to moderately severe Alzheimer's disease. Int J Geriatr Psychopharmacol 1:55-65
3. Cummings JL, Gorman DG, Shapira J (1993) Physostigmine ameliorates the delusions of Alzheimer's disease. Biol Psychiatry 33:536-541
4. Cummings JL, Kaufer D (1996) Neuropsychiatric aspects of Alzheimer's disease: the cholinergic hypothesis revisited. Neurology 47:876-883
5. De-Jong R, Ostersund OW, Roy GW (1989) Measurements of quality-of-life changes in patients with Alzheimer's disease. Clin Ther 11:545-554
6. Friedhoff LT, Ieni JR, Rogers SL, Pratt RD (1999) Donepezil provides long-term clinical benefits for patients with Alzheimer's disease. Int J Neuropsychopharmacol 2: S175
7. Friedhoff LT, Rogers SL (1997) Donepezil maintains activities of daily living in patients with mild to moderately severe Alzheimer's disease: results of a retrospective analysis. Eu J Neurol 4:S9
8. Galasko D, Edland SD, Morris JC, Clark C, Mohs R, Koss E (1995) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XI. Clinical milestones in patients with Alzheimer's disease followed over 3 years. Neurology 45: 1451-1455
9. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Brit J Psychiatry 140:566-572
10. Kaufer DI, Catt K, Pollock BG, Lopez OM, DeKosky ST (1998) Donepezil in Alzheimer's disease: relative cognitive and neuropsychiatric responses and impact on caregiver distress. Neurology 50:A89
11. Kaufer DI, Cummings JL, Christine D (1996) Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study. J Geriatr Psychiatry Neurol 9: 1-6
12. Knapp MJ, Knopman DS, Solomon PR, Pendlebury WW, Davis CS, Gracon SI (1994) A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. JAMA 271:985-991
13. Knopman D, Schneider L, Davis K, Talwalker S, Smith F, Hoover T, Gracon S (1996) Long-term tacrine (Cognex) treatment: Effects on nursing home placement and mortality. Neurology 47:166-177
14. Morris JC, Cyrus PA, Orazem J, Mas J, Bieber F, Ruzicka BB, Gulanski B (1998) Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease. Neurology 50:1222-1230
15. O'Connor DW, Pollitt PA, Hyde JB, Brook CPB, Reiss BB, Roth M (1988) Do general practitioners miss dementia in elderly patients? Brit Med J 297:1107-1110
16. Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT (1998) A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurology 50:136-145
17. Rosen WG, Mohs R, Davis KL (1984) A new rating scale for Alzheimer's disease. Am J Psychiatry 11:1356-1364
18. Ross GW, Abbott RD, Petrovitch H, Masaki KH, Murdaugh C, Trockman C, Curb JD, White LR (1997) Frequency and characteristics of silent dementia among elderly Japanese-American men. The Honolulu-Asia Aging Study. JAMA 277: 800-805
19. Teunisse S, Derix MM (1997) The interview for deterioration in daily living activities in dementia: agreement between primary and secondary caregivers. Int Psychogeriatr 9:155-162